Mealey's (June 29, 2018, 10:25 AM EDT) -- WASHINGTON, D.C. — Two pharmaceutical companies embroiled in a patent dispute over a sodium chloride solution of the drug dexmedetomidine (“dex”) presented in a sealed glass container recently briefed the Federal Circuit U.S. Court of Appeals on their respective positions (Hospira Inc. v. Amneal Pharmaceuticals LLC, No. 18-1522, Fed. Cir.)....